President and CEO of Exact Sciences Corp (NASDAQ:EXAS) Kevin T Conroy sold 134,057 shares of EXAS on 11/21/2017 at an average price of $59.5 a share. The total sale was $8 million.
Exact Sciences Corp operates in the healthcare sector. It is a diagnostics company focused on the early detection and prevention of colorectal cancer. Exact Sciences Corp has a market cap of $7.08 billion; its shares were traded at around $59.17 with and P/S ratio of 31.49. Exact Sciences Corp had annual average EBITDA growth of 18.60% over the past ten years.
CEO Recent Trades:
President and CEO Kevin T Conroy sold 134,057 shares of EXAS stock on 11/21/2017 at the average price of $59.5. The price of the stock has decreased by 0.55% since.President and CEO Kevin T Conroy sold 137,805 shares of EXAS stock on 11/09/2017 at the average price of $59.14. The price of the stock has increased by 0.05% since.
Directors and Officers Recent Trades:
Chief Science Officer Graham Peter Lidgard sold 45,775 shares of EXAS stock on 11/01/2017 at the average price of $53.6. The price of the stock has increased by 10.39% since.
For the complete insider trading history of EXAS, click here